Analytical Tool - Antibodies and Peptides in Oncology

BioSeeker Group AB
March 25, 2014
SKU: BIOS5221712
Analytical Tool - Antibodies and Peptides in Oncology

Analytical Tool – Antibodies and Peptides in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and peptide cancer drug competitive landscape. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are four products already appreciated by many of our customers:

Cancer Antibodies: Drug Target Atlas and Competitive Outlook

Cancer Peptides: From First-in-Class to Best-in-Class?

Antibodies in Oncology Drug Pipeline Update 2014

Peptides in Oncology Drug Pipeline Update 2014

The Package Includes:
  • A progress analysis on current and emerging drugs
  • Information on most companies active in R&D
  • Information on key industry related projects
  • Data from most important clinical trials
  • Information on early developmental stage projects
  • Possibility of performing advanced searches suited to your individual needs
This Tool will Assist You in:
  • Tracking cutting edge companies, therapies and new technologies
  • Rapid identification of partners & competitors
  • Laying down a comprehensive framework for further analysis of the field
  • Producing presentations surrounding the development of antibody and peptide drugs in cancer
  • Identifying emerging products & key areas of pharmaceutical R&D
This software application is a searchable database reflects the most recent advances in the field of antibody and peptide cancer drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker's software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.



More Oncology/Hematology reports by BioSeeker Group AB

Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014 by BioSeeker Group AB
Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014Abnormalities in the Wnt signaling pathway are associated with a large variety of human malignancies including tumors ...
Viral Carcinogenesis Drug Pipeline Update 2014 by BioSeeker Group AB
Viral Carcinogenesis Drug Pipeline Update 2014There is a strong association between viruses and the development of human malignancies. We now know that at least six ...
VEGF Signaling Pathway in Cancer Drug Pipeline Update 2014 by BioSeeker Group AB
VEGF Signaling Pathway in Cancer Drug Pipeline Update 2014There is now much evidence that VEGFR-2 is the major mediator of VEGF-driven responses in endothelial cells ...
TSLP Signaling Pathway in Oncology Drug Pipeline Update 2014 by BioSeeker Group AB
TSLP Signaling Pathway in Oncology Drug Pipeline Update 2014Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine that play various roles in a broad spectrum of ...
See all reports like this >>

 

SELECT A LICENSE

    Electronic Access
Global Site License Fulfilled by Publisher
  USD 22,312  
    Electronic Access
Single User Fulfilled by Publisher
  USD 8,925  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!